Veraxa Biotech AG
Last updated September 27, 2026
Organization details
- Legal name
- Veraxa Biotech AG
- Ownership
- Public
- Status
- Active
- Headquarters country
- Switzerland
- Ticker symbol
- VRXA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002079109
Board of directors
-
Christoph Rudiger Antz · Director · Chief Executive OfficerSince 2026
-
Christoph Samuel Ziegler · DirectorSince 2026
-
Marc Gruninger · DirectorSince 2026
-
Oliver Rolf Baumann · DirectorSince 2026
-
Warren Hosseinion · DirectorSince 2026
Chief executives
Christoph Rudiger Antz
· Chief Executive Officer
Since June 2026
Board connections
1 of this board's directors also sit on 3 other boards.
- via Warren Hosseinion
- via Warren Hosseinion
- via Warren Hosseinion
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $82,650
- 2 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 27, 2026 | Christoph Rudiger Antz Director, Officer (Chief Executive Officer) | Open-market purchase | +5,000 | $1.53 | $7,650 |
| Aug 27, 2026 | Oliver Rolf Baumann Director | Open-market purchase | +50,000 | $1.50 | $75,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.